Drug Type Autologous CAR-T |
Synonyms Anti-TRBC2 CAR-T Cells - Autolus |
Target |
Mechanism TRBC2 modulators(T cell receptor beta constant 2 modulators), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Peripheral T-Cell Lymphoma | Preclinical | GB | 30 Jan 2022 |